Long-term treatment with natalizumab in paediatric multiple sclerosis (MS)

被引：0
|
作者：
Talab, R. [1 ]
Talabova, M. [2 ]
机构：
[1] Charles Univ Prague, Dept Neurol, Fac Med Plzen, Prague, Czech Republic
[2] Univ Hosp Hradec Kralove, MS Ctr, Hradec Kralove, Czech Republic
来源：
MULTIPLE SCLEROSIS JOURNAL | 2019年 / 25卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P-70
引用
收藏
页码：471 / 472
页数：2
相关论文
共 50 条
  • [1] Long-term escalation therapy with natalizumab in paediatric and adolescent multiple sclerosis
    Bayas, A.
    Pitarokoili, K.
    Penzien, J.
    Gold, R.
    Hellwig, K.
    MULTIPLE SCLEROSIS JOURNAL, 2011, 17 : S70 - S70
  • [2] Natalizumab in paediatric multiple sclerosis: long-term results of 55 cases
    Ghezzi, A.
    Pozzilli, C.
    Moiola, L.
    Morra, V. Brescia
    Grimaldi, L. M. E.
    Lus, G.
    Rinaldi, F.
    Rocca, M. A.
    Trojano, M.
    Bianchi, A.
    Filippi, M.
    Comi, G.
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 : 301 - 302
  • [3] A new long-term treatment for multiple sclerosis, natalizumab
    Masson, C
    PRESSE MEDICALE, 2003, 32 (39): : 1831 - 1832
  • [4] Long-term safety evaluation of natalizumab for the treatment of multiple sclerosis
    Clerico, Marinella
    Artusi, Carlo Alberto
    Di Liberto, Alessandra
    Rolla, Simona
    Bardina, Valentina
    Barbero, Pierangelo
    De Mercanti, Stefania Federica
    Durelli, Luca
    EXPERT OPINION ON DRUG SAFETY, 2017, 16 (08) : 963 - 972
  • [5] Natalizumab in Multiple Sclerosis: Long-Term Management
    Clerico, Marinella
    Artusi, Carlo Alberto
    Di Liberto, Alessandra
    Rolla, Simona
    Bardina, Valentina
    Barbero, Pierangelo
    De Mercanti, Stefania Federica
    Durelli, Luca
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2017, 18 (05)
  • [6] Progression to disability milestones in multiple sclerosis with long-term natalizumab treatment
    Trojano, M.
    Butzkueven, H.
    Kappos, L.
    Wiendl, H.
    Spelman, T.
    Pellegrini, F.
    Chen, Y.
    Dong, Q.
    Koendgen, H.
    Belachew, S.
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 562 - 563
  • [7] Progression to disability milestones in multiple sclerosis with long-term natalizumab treatment
    Trojano, Maria
    Butzkueven, Helmut
    Kappos, Ludwig
    Wiendl, Heinz
    Spelman, Tim
    Pellegrini, Fabio
    Pellegrini, Fabio
    Dong, Qunming
    Kondgen, Harold
    Belachew, Shibeshih
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 (06) : NP2 - NP2
  • [8] The long-term impact of natalizumab on multiple sclerosis: to continue or to stop?
    Sangalli, F.
    Moiola, L.
    Radaelli, M.
    Ferre, L.
    Esposito, F.
    Colombo, B.
    Martinelli, V.
    Comi, G.
    EUROPEAN JOURNAL OF NEUROLOGY, 2016, 23 : 823 - 823
  • [9] EARLY PREDICTION OF LONG-TERM RESPONSE TO NATALIZUMAB IN MULTIPLE SCLEROSIS
    Raffel, Joel
    Gafson, Arie
    Dahdaleh, Samer
    Nicholas, Richard
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2015, 86 (11):
  • [10] The long-term impact of natalizumab on multiple sclerosis: to continue or to stop?
    Sangalli, F.
    Moiola, L.
    Radaelli, M.
    Esposito, F.
    Colombo, B.
    Rodegher, M.
    Martinelli-Boneschi, F.
    Martinelli, V.
    Comi, G.
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 300 - 300
12345